Todos Medical (Todos Medical) EPS (Basic) : $-0.03 (TTM As of Sep. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Todos Medical EPS (Basic)?

Todos Medical's basic earnings per share (Basic EPS) for the three months ended in Sep. 2022 was $-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.03.

Todos Medical's EPS (Diluted) for the three months ended in Sep. 2022 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.03.

Todos Medical's EPS without NRI for the three months ended in Sep. 2022 was $-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2022 was -0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Todos Medical EPS (Basic) Historical Data

The historical data trend for Todos Medical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Todos Medical EPS (Basic) Chart

Todos Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EPS (Basic)

Get a 7-Day Free Trial

-0.04

-0.01

-0.13

-0.11

-0.06

Todos Medical Quarterly Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EPS (Basic)	Get a 7-Day Free Trial												-0.01	-0.02	-	-0.01	-

Todos Medical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Todos Medical's Basic EPS for the fiscal year that ended in Dec. 2021 is calculated as

Basic EPS (A: Dec. 2021 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-43.314	-	0)	/	679.575
	=	-0.06

Todos Medical's Basic EPS for the quarter that ended in Sep. 2022 is calculated as

Basic EPS (Q: Sep. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.63	-	0)	/	1279.536
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

Todos Medical (OTCPK:TOMDF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Todos Medical EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Todos Medical's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Todos Medical (Todos Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Todos Medical Ltd (OTCPK:TOMDF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203

Website

https://www.todosmedical.com

Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.

Executives

Gerald Commissiong	director, officer: CEO and Director	675 ALMANOR AVENUE, SUNNYVALE CA 94085
Strategic Investment Holdings, Llc	10 percent owner	875 CARRETERA 693, SUITE 201, DORADO PR 00646